An Overview of Clinical Spectrum and Heterogeneity of Spondyloarthropathies
Overview
Authors
Affiliations
Ankylosing spondylitis and related spondyloarthropathies form a family of rheumatic diseases that are characterized by inflammatory peripheral and axial arthritis, with predilection for sacroiliitis, and a remarkably strong association with a genetic marker, HLA-B27. The association with B27 has provided a great impetus to the epidemiologic studies of spondyloarthropathies and also helped broaden the clinical spectrum of these diseases. There are at least six subtypes of B27, and the x-ray crystallographic structure of the common B27 subtype (B*2705) is now known. Endogenous peptides bound in the B27 antigen-binding cleft have been isolated and all seem to be nonamers (i.e., nine amino acids long).
Zhong C, Liang J, Chen Z, Zhong L, Sun G, Xie W Dis Markers. 2022; 2022:4942599.
PMID: 36157216 PMC: 9507730. DOI: 10.1155/2022/4942599.
Rocha Loures M, Macedo L, Reis D, Oliveira C, Meneguetti J, Martines G Mediators Inflamm. 2018; 2018:1395823.
PMID: 29849482 PMC: 5933012. DOI: 10.1155/2018/1395823.
Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis.
Yazgan S, Celik U, Isik M, Karahan Yesil N, Baki A, Sahin H Int Ophthalmol. 2016; 37(1):139-145.
PMID: 27154720 DOI: 10.1007/s10792-016-0239-y.
Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.
Escudero-Vilaplana V, Ramirez-Herraiz E, Alanon-Plaza E, Trovato-Lopez N, Garcia-Vicuna R, Carreno-Perez L Int J Clin Pharm. 2015; 37(5):808-14.
PMID: 25910480 DOI: 10.1007/s11096-015-0124-1.
Vargas-Alarcon G, Londono J, Hernandez-Pacheco G, Pacheco-Tena C, Castillo E, Cardiel M Ann Rheum Dis. 2002; 61(8):714-7.
PMID: 12117677 PMC: 1754177. DOI: 10.1136/ard.61.8.714.